Tekla Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,528
| Closed | -$452K | – | 189 |
|
|
2018
Q1 | $452K | Buy |
+1,528
| New | +$452K | 0.02% | 174 |
|
|
2017
Q4 | – | Sell |
-1,034
| Closed | -$341K | – | 164 |
|
|
2017
Q3 | $341K | Buy |
+1,034
| New | +$341K | 0.01% | 148 |
|
|
2015
Q1 | – | Sell |
-1,348
| Closed | -$11.8M | – | 106 |
|
|
2014
Q4 | $11.8M | Sell |
1,348
-809
| -38% | -$7.11M | 0.55% | 42 |
|
|
2014
Q3 | $9.64M | Hold |
2,157
| – | – | 0.45% | 42 |
|
|
2014
Q2 | $13.2M | Hold |
2,157
| – | – | 1.21% | 21 |
|
|
2014
Q1 | $9.83M | Buy |
+2,157
| New | +$9.83M | 0.98% | 27 |
|